ATE131532T1 - Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen - Google Patents

Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen

Info

Publication number
ATE131532T1
ATE131532T1 AT87111591T AT87111591T ATE131532T1 AT E131532 T1 ATE131532 T1 AT E131532T1 AT 87111591 T AT87111591 T AT 87111591T AT 87111591 T AT87111591 T AT 87111591T AT E131532 T1 ATE131532 T1 AT E131532T1
Authority
AT
Austria
Prior art keywords
pdgf
chain
chains
disclosed
biologically active
Prior art date
Application number
AT87111591T
Other languages
English (en)
Inventor
Mark J Murray
James D Kelly
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/896,485 external-priority patent/US4766073A/en
Priority claimed from US06/941,970 external-priority patent/US4849407A/en
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE131532T1 publication Critical patent/ATE131532T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87111591T 1986-08-13 1987-08-11 Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen ATE131532T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/896,485 US4766073A (en) 1985-02-25 1986-08-13 Expression of biologically active PDGF analogs in eucaryotic cells
US06/941,970 US4849407A (en) 1986-08-13 1986-12-15 Biologically active mosaic proteins
US06/942,161 US4845075A (en) 1985-02-25 1986-12-15 Biologically active B-chain homodimers
US06/942,484 US4889919A (en) 1986-08-13 1986-12-15 Biologically active PDGF derived A-chain homodimers

Publications (1)

Publication Number Publication Date
ATE131532T1 true ATE131532T1 (de) 1995-12-15

Family

ID=27505982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87111591T ATE131532T1 (de) 1986-08-13 1987-08-11 Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen

Country Status (7)

Country Link
EP (1) EP0259632B1 (de)
JP (1) JPH085797B2 (de)
AT (1) ATE131532T1 (de)
AU (1) AU7681687A (de)
CA (1) CA1341398C (de)
DE (1) DE3751632T2 (de)
DK (1) DK176036B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
EP0682110A1 (de) * 1987-04-22 1995-11-15 Chiron Corporation Für PDGF-A-Ketten Polypeptiden kodierende, rekombinante DNA
US6939849B1 (en) 1987-04-22 2005-09-06 Chiron Corporation Recombinant PDGF A-chain homodimers and methods of use
EP0422125B1 (de) * 1988-06-30 1996-10-23 Cor Therapeutics, Inc. Plättchen blockierende peptide
EP0366816A1 (de) * 1988-10-31 1990-05-09 Rorer Biotechnology Inc. Rekombinierte A-Kette von Blutplättchen Wachstumsfaktor aus Endothelzellen
US5968778A (en) * 1989-01-12 1999-10-19 Jurgen Hoppe PDGF-AB, preparation process and pharmaceuticals containing them
DE3900770A1 (de) * 1989-01-12 1990-07-26 Juergen Prof Dr Hoppe Verfahren zur herstellung von pdgf-a und pdgf-aa
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
US5272064A (en) * 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
DE69102651T2 (de) * 1990-07-23 1994-10-06 Zymogenetics, Inc., Seattle, Wash. Proteaseresistenter pdgf und dessen verwendungen.
EP0566673A1 (de) * 1990-12-21 1993-10-27 Creative Biomolecules, Inc. Biosynthetische pdgf-antagonisten
GB9101645D0 (en) * 1991-01-25 1991-03-06 British Bio Technology Compounds
ZA932179B (en) * 1992-03-30 1994-09-26 Schering Corp Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
CA2137367A1 (en) * 1992-06-05 1993-12-23 Amrit K. Judd Peptides having platelet-derived growth factor (pdgf) activity
DE4228458A1 (de) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronische Expressionseinheiten und deren Verwendung
DE4228457A1 (de) * 1992-08-27 1994-04-28 Beiersdorf Ag Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
ZA942206B (en) * 1993-04-01 1994-10-31 Amgen Inc Biologically active polypeptide fusion dimers
EP1486565B1 (de) * 1995-10-11 2007-11-21 Novartis Vaccines and Diagnostics, Inc. Kombinierung von PDGF, KGF, IGF und IGFBP für Wundheilung
DE69725881T2 (de) 1996-12-13 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Verfahren zur expression von heterologen proteinen in hefe
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH064673B2 (ja) * 1980-11-10 1994-01-19 ゲネンテツク・インコ−ポレ−テツド ハイブリド型ヒト白血球インタフエロン
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
AU600885B2 (en) * 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells

Also Published As

Publication number Publication date
EP0259632B1 (de) 1995-12-13
DE3751632T2 (de) 1996-06-13
JPH085797B2 (ja) 1996-01-24
EP0259632A1 (de) 1988-03-16
JPS63119682A (ja) 1988-05-24
DK421787D0 (da) 1987-08-12
DK176036B1 (da) 2006-01-09
CA1341398C (en) 2002-11-19
DK421787A (da) 1988-02-14
DE3751632D1 (de) 1996-01-25
AU7681687A (en) 1988-02-18

Similar Documents

Publication Publication Date Title
ATE131532T1 (de) Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen
DE3588218D1 (de) Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
EP0161640A3 (de) Mit "Vogelretrovirus-Rinderwachstumshormon"-DNS transformierte eingekapselte Mausezellen und Verfahren zum Verabreichen von BGH in vivo
NO914387D0 (no) Fremstilling av hemoglobin og dens analoger i bakterier og gjaer
ATE125869T1 (de) Wachstumshormonfusionsproteine.
DE3650538D1 (de) Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
DE3688900D1 (de) Expression von protein c.
ATE404668T1 (de) Wachstumsfaktor-homologe zvegf-3
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
FI891848A0 (fi) Framstaellning av isolerade proteinhaltiga material med anvaendning av rekombinantkoppvirusvektorer fraon faoglar.
JPS642572A (en) Polypeptide, dna and use thereof
NO873437D0 (no) Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon.
ES2065915T3 (es) Procedimiento para aumentar la expresion de polipeptidos en un cultivo de celula recombinante.
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
Nishio IRON NUTRITION-MEDIATED CHLOROPLAST DEVELOPMENT (THYAKOIDS, PHOTOSYNTHESIS)
JPS6212723A (ja) 魚類の成長ホルモン
TH3929A (th) โพลีเพปไทด์ของคนที่ออกฤทธิ์ทางสรีรวิทยาชนิดที่เป็นสารใหม่สารใหม่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time